$21.36
+0.71 (+3.44%)
Open$21.00
Previous Close$20.65
Day High$21.45
Day Low$20.05
52W High$33.20
52W Low$13.89
Volume—
Avg Volume502.9K
Market Cap769.35M
P/E Ratio—
EPS$-3.87
SectorBiotechnology
Analyst Ratings
Strong Buy
17 analysts
Price Target
+254.9% upside
Current
$21.36
$21.36
Target
$75.80
$75.80
$52.19
$75.80 avg
$91.23
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 16.77M | 78.02M | 75.69M |
| Net Income | -88,834,401 | -16,723,517 | -20,379,208 |
| Profit Margin | -529.8% | -21.4% | -26.9% |
| EBITDA | -102,782,066 | -28,105,243 | -27,281,553 |
| Free Cash Flow | — | -11,355,754 | -12,035,038 |
| Rev Growth | — | -7.7% | +21.3% |
| Debt/Equity | 0.00 | 0.34 | 0.31 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.76 | +2.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.01 | +0.66% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.05 | +0.14% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $468.42 | +0.35% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.03 | +0.90% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $288.18 | +0.62% | 64.3 | 37.13B |